Management of small-cell lung cancer

被引：32
作者：
Thatcher, N [1 ]
Faivre-Finn, C [1 ]
Lorigan, P [1 ]
机构：
[1] Christie Hosp, Manchester, Lancs, England
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
10.1093/annonc/mdi700
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：235 / 239
页数：5
相关论文
共 50 条
[1]   Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: A prospective European organization for research and treatment of cancer-lung cancer group phase III trial-08923 [J].
Ardizzoni, A ;
Tjan-Heijnen, VCG ;
Postmus, PE ;
Buchholz, E ;
Biesma, B ;
Karnicka-Mlodkowska, H ;
Dziadziuszko, R ;
Burghouts, J ;
van Meerbeeck, JP ;
Gans, S ;
Legrand, C ;
Debruyne, C ;
Giaccone, G ;
Manegold, C .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (19) :3947-3955
[2]  
ARRIAGADA R, 2004, JNCI-J NATL CANCER I, V87, P183
[3]   Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission [J].
Aupérin, A ;
Arriagada, R ;
Pignon, JP ;
Le Péchoux, C ;
Gregor, A ;
Stephens, RJ ;
Kristjansen, PEG ;
Johnson, BE ;
Ueoka, H ;
Wagner, H ;
Aisner, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (07) :476-484
[4]   The role of cisplatin in the treatment of small-cell lung cancer? [J].
Berghmans, T ;
Paesmans, M ;
Sculier, JP .
ANNALS OF ONCOLOGY, 2001, 12 (05) :585-586
[5]  
BHASKARAN R, 2002, HIGH DOSE CHEMOTHERA, P181
[6]   Prognostic factors of small cell lung cancer [J].
Buccheri, G ;
Ferrigno, D .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (02) :445-+
[7]  
BUCHHOLZ E, 2003, P AN M AM SOC CLIN, V22, P640
[8]   PRETREATMENT PROGNOSTIC FACTORS AND SCORING SYSTEM IN 407 SMALL-CELL LUNG-CANCER PATIENTS [J].
CERNY, T ;
BLAIR, V ;
ANDERSON, H ;
BRAMWELL, V ;
THATCHER, N .
INTERNATIONAL JOURNAL OF CANCER, 1987, 39 (02) :146-149
[9]   Chemotherapy of small cell lung cancer: state of the art [J].
Chrystal, K ;
Cheong, K ;
Harper, P .
CURRENT OPINION IN ONCOLOGY, 2004, 16 (02) :136-140
[10]   Thoracic radiotherapy for limited-stage small cell lung cancer: Issues of timing, volumes, dose, and fractionation [J].
Erridge, SC ;
Murray, N .
SEMINARS IN ONCOLOGY, 2003, 30 (01) :26-37
12345